Literature DB >> 19190923

Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.

Qipeng Zhang1, Xiaoguang Zhang, Anyang Sun.   

Abstract

In addition to tau hyperphosphorylation, tau truncation is also detected in Alzheimer's disease (AD) patients. In the brain of AD transgenic mouse models, the pathological details of truncated tau are not well characterized. In this study, we analyzed spatial relationships among tau truncation, tau phosphorylation and neurodegeneration or tangle formation in a tau(P301L) single transgenic mouse model and a triple transgenic mouse model that produces both amyloid plaques, and neurofibrillary tangles. During development of tau pathology, the spatial relationship between hyperphosphorylation and truncation of tau exhibited a shift from colocalization at low densities of hyperphosphorylated tau to partial dissociation at high densities. Importantly, we detected a few neurons that contained abundant truncated tau but were lacking hyperphosphorylation, and these neurons exhibited remarkable nuclear condensation. In the case of colocalization, truncated tau was commonly associated with high immunoreactivity of hyperphosphorylated tau and dense Gallyas silver staining. Taken together, our study shows that tau truncation appears after tau hyperphosphorylation in the brain of two transgenic mouse models, and that accumulation of truncated tau, in the absence or the presence of phosphorylated tau, is closely associated with a subset of neurons undergoing degeneration or containing neurofibrillary tangles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190923     DOI: 10.1007/s00401-009-0491-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

Authors:  María José Pérez; Katiana Vergara-Pulgar; Claudia Jara; Fabian Cabezas-Opazo; Rodrigo A Quintanilla
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Caspase activation precedes and leads to tangles.

Authors:  Alix de Calignon; Leora M Fox; Rose Pitstick; George A Carlson; Brian J Bacskai; Tara L Spires-Jones; Bradley T Hyman
Journal:  Nature       Date:  2010-03-31       Impact factor: 49.962

3.  Improving the specificity of immunological detection in aged human brain tissue samples.

Authors:  Anyang Sun; Mei Liu; Guoying Bing
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-12-02

4.  BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells.

Authors:  M Del Campo; C R Oliveira; W Scheper; R Zwart; C Korth; A Müller-Schiffmann; G Kostallas; H Biverstal; J Presto; J Johansson; J J Hoozemans; C F Pereira; C E Teunissen
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

Review 5.  Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Authors:  Thimmappa S Anekonda; Joseph F Quinn
Journal:  Biochim Biophys Acta       Date:  2011-09-08

6.  Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice.

Authors:  Anjanet Loon; Frank Zamudio; Awa Sanneh; Breanna Brown; Shayna Smeltzer; Milene L Brownlow; Zainuddin Quadri; Melinda Peters; Edwin Weeber; Kevin Nash; Daniel C Lee; Marcia N Gordon; Dave Morgan; Maj-Linda B Selenica
Journal:  Geroscience       Date:  2021-08-19       Impact factor: 7.713

Review 7.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

8.  A synergic role of caspase-6 and caspase-3 in Tau truncation at D421 induced by H2O 2.

Authors:  Hong Zhao; Wenjuan Zhao; Kenghoe Lok; Zejian Wang; Ming Yin
Journal:  Cell Mol Neurobiol       Date:  2013-12-21       Impact factor: 5.046

9.  Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice.

Authors:  Holly J Garringer; Jill Murrell; Neeraja Sammeta; Anita Gnezda; Bernardino Ghetti; Ruben Vidal
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

10.  Structure and pathology of tau protein in Alzheimer disease.

Authors:  Michala Kolarova; Francisco García-Sierra; Ales Bartos; Jan Ricny; Daniela Ripova
Journal:  Int J Alzheimers Dis       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.